These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 21600141)

  • 1. [Strengthening the role of statin therapy in atherosclerosis for the prevention and treatment of cerebrovascular disease].
    Liu LP; Wang YJ
    Zhonghua Nei Ke Za Zhi; 2011 Apr; 50(4):275-7. PubMed ID: 21600141
    [No Abstract]   [Full Text] [Related]  

  • 2. Suboptimal use of statin therapy in elderly patients with atherosclerosis: a population-based study.
    Al-Omran M; Mamdani MM; Lindsay TF; Melo M; Juurlink DN; Verma S;
    J Vasc Surg; 2008 Sep; 48(3):607-12. PubMed ID: 18585886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Have statins changed the natural history of atheromatous disease and its treatment?
    Samson RH
    Semin Vasc Surg; 2008 Sep; 21(3):160-4. PubMed ID: 18774452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Statin" drugs, mortality, and stroke prevention.
    Stiffman MN
    J Fam Pract; 1997 Oct; 45(4):293-4. PubMed ID: 9379151
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of statin adherence on cerebrovascular disease in primary prevention.
    Perreault S; Ellia L; Dragomir A; Côté R; Blais L; Bérard A; Lalonde L
    Am J Med; 2009 Jul; 122(7):647-55. PubMed ID: 19559167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statins for primary prevention of cardiovascular and cerebrovascular events in diabetic patients without established cardiovascular diseases: a meta-analysis.
    Chen YH; Feng B; Chen ZW
    Exp Clin Endocrinol Diabetes; 2012 Feb; 120(2):116-20. PubMed ID: 22187291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statin therapy--Part II: Clinical considerations for cardiovascular disease.
    Sadowitz B; Seymour K; Costanza MJ; Gahtan V
    Vasc Endovascular Surg; 2010 Aug; 44(6):421-33. PubMed ID: 20547576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Under-utilization of statin medications in patients with peripheral artery disease or cerebrovascular disease.
    Armstrong EJ; Waldo SW
    Vasc Med; 2018 Jun; 23(3):241-242. PubMed ID: 29600738
    [No Abstract]   [Full Text] [Related]  

  • 9. JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice.
    ; ; ; ; ;
    Heart; 2005 Dec; 91 Suppl 5(Suppl 5):v1-52. PubMed ID: 16365341
    [No Abstract]   [Full Text] [Related]  

  • 10. Beneficial effects of statin therapy on infection related mortality in patients with atherosclerotic and cardiovascular disease.
    Mahajan R; Gupta R; Sharma A
    Anesth Analg; 2008 Jan; 106(1):352. PubMed ID: 18165612
    [No Abstract]   [Full Text] [Related]  

  • 11. Statin therapy in ARAS: beyond cholesterol lowering.
    Meier P
    Am J Hypertens; 2008 Oct; 21(10):1075. PubMed ID: 18806771
    [No Abstract]   [Full Text] [Related]  

  • 12. Does the preventive effect of different drugs depend on location of the atherosclerotic process?
    Poredos P; Jezovnik MK
    Int Angiol; 2008 Aug; 27(4):274-80. PubMed ID: 18677288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statin pleiotropy: a popular concept but clinical significance unclear.
    Robinson JG; Schrott H
    Cardiovasc Drugs Ther; 2007 Apr; 21(2):81-3. PubMed ID: 17417697
    [No Abstract]   [Full Text] [Related]  

  • 14. The utility of cardiovascular drugs in the treatment of cerebrovascular disease.
    Bösel J; Amiri H
    Curr Opin Investig Drugs; 2010 Sep; 11(9):1015-24. PubMed ID: 20730696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gap between guidelines and practice: attainment of treatment targets in patients with primary hypercholesterolemia starting statin therapy. Results of the 4E-Registry (Efficacy Calculation and Measurement of Cardiovascular and Cerebrovascular Events Including Physicians' Experience and Evaluation).
    Assmann G; Benecke H; Neiss A; Cullen P; Schulte H; Bestehorn K
    Eur J Cardiovasc Prev Rehabil; 2006 Oct; 13(5):776-83. PubMed ID: 17001218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An emerging paradigm in atherosclerosis: focus on subclinical disease.
    Miller M
    Postgrad Med; 2009 Mar; 121(2):49-59. PubMed ID: 19332962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atherosclerosis imaging in statin intervention trials.
    Yanai H; Yoshida H; Tomono Y; Tada N
    QJM; 2007 May; 100(5):253-62. PubMed ID: 17456609
    [No Abstract]   [Full Text] [Related]  

  • 18. Risk associated with statin treatment.
    Kjekshus J
    J Am Coll Cardiol; 2008 Jan; 51(1):91; author reply 92. PubMed ID: 18174047
    [No Abstract]   [Full Text] [Related]  

  • 19. Statin intolerance: more questions than answers.
    Guyton JR; Campbell KB; Lakey WC
    Expert Rev Clin Pharmacol; 2014 Jan; 7(1):1-3. PubMed ID: 24308790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary prevention of atherosclerotic cardiovascular disease: the high public burden of low individual risk.
    Lauer MS
    JAMA; 2007 Mar; 297(12):1376-8. PubMed ID: 17384436
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.